We apologize, but this video has failed to load. “The Board of Directors has unanimously chosen Julie Kim to lead Takeda into the next chapter, building on the company’s success under Christophe Weber ...

Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker. Weber – who was briefly chief operating officer of Takeda ...

Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, ...

Takeda has announced the appointment of Julie Kim as successor to Christophe Weber, its current president, CEO and representative director, effective from June 2026. The decision was unanimously ...

will succeed CEO Christophe Weber, who plans to step down in June next year. The U.S. is by far the largest market for Takeda, generating about half of the company’s revenue. Founded in 1781 ...

“The list of what is on top of our mind is much broader than in the past,” says Christophe Weber, Takeda’s president and CEO, during a virtual conversation focused on pursuing growth in a ...